iQure Pharma is a global biotech company that develops new therapeutics for patients and physicians.
iQure Pharma's investors include Michael J. Fox Foundation, National Institutes of Health, OKG Capital, Keiretsu Forum Northwest, Keiretsu Forum.
iQure Pharma is headquartered in Wilmington, United States.
iQure Pharma is a global biotech company that develops new therapeutics for patients and physicians.
iQure Pharma is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"iQure Pharma — Funding & Investors." VCBacked, June 18, 2026, https://www.vcbacked.co/company/iqure-pharma. Accessed July 19, 2026.
VCBacked. (2026). iQure Pharma — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/iqure-pharma
{{cite web |title=iQure Pharma — Funding & Investors |url=https://www.vcbacked.co/company/iqure-pharma |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated